Clinical Study

The Safety and Efficacy of Routine Administration of Intracameral Vancomycin during Cataract Surgery

Table 2

The means and distributions with standard deviations of the intraoperative and postoperative outcomes among the group that received and the group that did not receive intracameral vancomycin during cataract surgery.

Outcome measureDid not receive intracameral vancomycin
()
Did receive intracameral vancomycin
()
value

Posterior capsular tearYes = 56 (0.5%)
No = 11,277 (99.50%)
Yes = 49 (0.53%)
No = 9,337 (99.47%)
Anterior vitrectomy performed Yes = 44 (0.39%)
No = 11,289 (99.61%)
Yes = 35 (0.37%)
No = 9,351 (99.63%)
Dislocation of lens fragments into the posterior segmentYes = 14 (0.13%)
No = 11,319 (99.87%)
Yes = 9 (0.10%)
No = 9,377 (99.90%)
Complex procedure billed Yes = 985 (8.7%)
No = 10,348 (91.3%)
Yes = 808 (8.6%)
No = 8,578 (91.4%)
Postoperative BSCVA (logMAR) 0.15 (0.15) 0.13 (0.14)
Postoperative endophthalmitis Yes = 11 (0.09%)
No = 11,322 (99.9%)
Yes = 0 (0%)
No =9,386 (100%)